circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
Liver Physiol. 7): G52-G57, 1983.-Two dissimilar hemodynamic hypotheses, the "backward flow" theory and the "forward flow" theory, have been advanced to define splanchnic hemodynamics in portal hypertension.
An animal model with portal hypertension and high-grade portal-systemic shunting, the portal vein-stenotic rat, was studied to determine whether a hemodynamic picture compatible with either theory would develop. Splanchnit and systemic hemodynamics and portal-systemic shunting were measured by radioactive microsphere techniques. The portal-hypertensive rats (portal pressure, 12.8 t 0.5 vs. 8.3 t 0.4 mmHg) with greater than 95% portal-systemic shunting had a 60% increase in portal venous inflow (23.46 -t: 2.54 vs. 14.97 ,t 1.61 ml/min; P c 0.01) with a concomitant 50% decrease in splanchnic arteriolar resistance (3.86 t 0.43 vs. 7.60 t 0.80 dyne s . cm-" x 10"; P < 0.001) compared with control rats. Cardiac index (391 t 17 vs. 250 t 20 ml.min-'* kg-') was elevated 50% (P < O.OOl), and total peripheral resistance (7.1 t 0.4 vs. 11.7 t 0.8 dyns= crne5 x 104) was decreased 60% (P < 0.001). The resistance to portal blood flow in portal vein-stenotic rats (4.77 t 0.57 dyn l s l crne5 x 104) was similar to the resistance to portal blood flow in control rats (4.82 t 0.43 dyn+ cm-" X 104), indicating that the hyperdynamic portal venous inflow, not resistance, provided the main impetus for maintaining the elevated portal venous pressure. The splanchnic hemodynamic observations directly support the forward flow theory of portal hypertension.
The relation between splanchnic arteriolar resistance and total peripheral resistance (r = 0.67; P < 0.01) indicated that the systemic hemodynamic parameters were secondarily altered by the splanchnic hemodynamic changes. This animal model of chronic portal hypertension gave evidence for a generalized splanchnic arteriolar vasodilation occurring in the presence of high-grade portal-systemic shunting.
hepatic blood flow; portal-systemic shunting; splanchnic hemodynamics; microspheres AN INCREASED RESISTANCE to portal blood flow, whether intrahepatic or extrahepatic, will elevate portal venous pressure. As a consequence, preexisting collateral veins dilate, forming portal-systemic shunts that, in some instances, carry the major portion of blood flow away from the portal vein into the systemic veins. These naturally occurring shunts, at least partially, counteract the increased resistance to portal blood flow; nevertheless, the portal hypertension persists (21, 28).
Two hemodynamic theories have been advanced to explain why portal pressure remains elevated. The "backward flow" theory (1, 18) attributes the portal hypertension solely to increased portal venous resistance and, with this, implies a passive congestion within the portal venous system. In contrast, the "forward flow" theory (5,27,30) proposes an increased splanchnic blood flow that maintains the portal hypertension, despite correction of portal venous resistance by the portal-systemic shunts.
Previous investigations have shown that a surgically created portal vein stenosis in the rat produces chronic portal hypertension and the development of portal-systemic shunts (4, 10, 11). The present study examines systemic and splanchnic hemodynamics in this model in order to determine which theory of portal hypertension more closely describes the changes that occur.
MATERIALS AND METHODS
Male Sprague-Dawley rats (Charles River Laboratories, Cambridge, MA) were used. The animals were housed in individual stainless steel, screened floor cages and allowed free access to rat chow (Ralston Purina, St. Louis, MO) and water until the time of study.
The operative procedure for the portal vein stenosis has been previously described (4). In brief, the portal vein was isolated, and the stenosis was created by a single ligature of 3-O silk around the portal vein and a 20.gauge, blunt-tipped needle. The needle was then removed and the portal vein was allowed to reexpand distal to the stenosis. In the sham-operated control rats, the portal vein was isolated, but no needle or ligature was placed about the portal vein.
Hemodynamic Study
The techniques used for the hemodynamic measurements in normal a.nd portal hypertensive animals have been detailed in previous communications from this laboratory (4, 7, 8). Briefly, the animals were anesthetized with ketamine HCl (100 mg/kg body wt im). The left femoral and right carotid arteries were exposed and cannulated with PE-50 catheters. The catheters were G53 connected to a Statham P-23.Db strain-gauge transducer, and permanent recordings of arterial pressure were made on a Grass model 7D inscription recorder. The right carotid catheter was advanced into the left ventricle during continuous pressure monitoring. Left ventricular and arterial blood pressure were monitored throughout the study. The body temperature was maintained at 37.0 t 0.5OC (rectal) Cardiac output and regional organ blood flow were measured using a radioactive microsphere technique with reference sample method (8, 14). The reference sample was withdrawn from the left femoral artery catheter into a preweighed syringe for 90 s at an approximate rate of 1.0 ml/min using a Harvard pump (Harvard Apparatus, Millis, MA). Ten seconds after beginning withdrawal of the reference sample, approximately 50,000 polymeric resin, 51Cr-labeled microspheres (15 t 3 pm diam; sp act, 40 mCi/g; New England Nuclear, Boston, MA) were injected into the left ventricle over lo-15 s. The catheter was flushed with 0.2 ml of 0.9% NaCl. A volume of 0.9% NaCl equal to the reference sample was reinfused, and the arterial blood pressure was monitored to ensure a stable preparation.
A small parasagittal incision (1.5-2.0 cm) was made in the left upper abdomen through the skin and muscle. The spleen was exposed by retraction on the perisplenic fat, with care taken to avoid undue manipulation.
Intrasplenic pressure was measured by inserting a fluid-filled, 20-gauge needle into the splenic parenchyma. The needle was connected by a 6-cm tubing to a Statham straingauge transducer calibrated for venous pressure. The external zero reference point was placed at the midportion of the animal. The pressure reading was accepted when a stable recording was produced and respiratory variations were observed. Hemostasis was obtained after needle removal by applying cyanoacrylate glue (Eastman Kodak, Rochester, NY).
Portal-systemic shunting was quantitated using the technique described by Chojkier and Groszmann (4) and Groszmann et al. (8) . An intrasplenic injection of approximately 30,000 57Co-labeled microspheres (15 t 3 pm; sp act, 10 mCi/g) was made over 20 s. Hemostasis was achieved by cyanoacrylate glue. The spleen was replaced into the abdominal cavity.
The abdominal cavity was entered 10 min later through a midline incision. Portal pressure was measured using a 21-gauge Butterfly needle connected to a straingauge transducer. The identical external zero reference point for measuring intrasplenic pressure was used. The needle was directly placed into the portal vein in control animals or into the distal superior mesenteric vein in portal vein-stenotic animals.
The animal was killed with a bolus of saturated KCl. The abdominal organs, kidneys, lungs, testes, brain, and portions of skin and muscle were dissected and weighed. The radioactivity (counts per minute) of each organ was determined in a gamma scintillation counter (Packard, Downers Grove, IL). The larger organs were dissected into smaller portions for uniform geometry within the scintillation counting tubes. The error in the measurement of the radioactivity induced by the spillover of 51Cr (energy window used at 280-360 keV) into the 57Co channel (energy window at 50-200 keV) was corrected by using 51Cr and 57Co standards.
Hemodynamic
Calculations Cardiac output and regional organ blood flow. Cardiac output (CO) and organ blood flow were calculated as follows from their respective formulas (8, 14) injected radioactivity (cpm) CO (ml/min) = x reference blood flow (ml/min) reference blood radioactivity (cpm) organ blood flow (ml/min) organ radioactivity (cpm)
x reference blood flow (ml/min) = reference blood radioactivity (cpm)
At least 300 microspheres were trapped in both the reference sample and organs to ensure validity of the measurement (14). Cardiac index was calculated as cardiac output per kilograms body weight. Organ blood flow was also expressed as milliliters per minute per grams organ weight.
Portal venous inflow (PVI) was the sum of blood flow to stomach, spleen, small and large intestines, pancreas, and mesentery. This calculation would represent the total blood flow entering into the portal venous system. Portal-systemic shunting. Portal-systemic shunting (PSS) was calculated as follows (4) PSS (%) = lung radioactivity (cpm) (liver + lung) radioactivity (cpm)
x 100
Because PSS would alter the amount of portal venous blood flow (PBF) perfusing the liver, PBF was corrected for PSS in the following manner (4) PBF (ml/min) = PVI -PVI x PSS% 100
Note that, with negligible PSS of less than I%, PBF was equivalent to PVI. Hepatic arterial flow was calculated directly from the liver radioactivity. Total hepatic blood flow was the sum of hepatic arterial flow and PBF. For calculating total peripheral resistance, AP equaled mean arterial pressure minus right atria1 pressure, and & was cardiac output. When measured, the right atrial pressure was O-l mmHg and was not considered to make a significant contribution to the calculation. Vascular resistance of the stomach, intestines, and spleen was calculated from mean arterial minus .portal pressure and the organ blood flow (ml/min). Splanchnic arteriolar resistance (R,) was calculated as the sum of parallel resistances in the stomach (R,t), intestines (Ri), and spleen (R,,) (9)
BREDFELDT, AND GROSZMANN Portal venous resistance was calculated from portal pressure and PVI.
The results were expressed as means t SE. Statistical analysis was performed using Student's t test and coefficient of correlation by linear regression. Results are considered significant at P < 0.05 (24).
RESULTS
Twelve portal vein-stenotic rats and 14 control rats were studied. The body weight at the time of surgery was 366 t 18 g for stenotic rats and 339 t 10 g for control rats (P = NS). At the time of the hemodynamic study, the body weight in stenotic rats (343 t 10 g) was less than in control rats (387 t 11; P < 0.01). The hemodynamic study was performed at a mean of 13 and 15 days after surgery for stenotic and control rats, respectively.
Portal Pressure
Pressure was significantly higher in stenotic rats than in control rats when measured as intrasplenic pressure (11.7 t 0.5 vs. 7.9 t 0.5 mmHg; P < 0.001) or portal pressure (12.8 t 0.5 vs. 8.3 t 0.4 mmHg; P < 0.001 by unpaired t test). There was no difference between intrasplenic pressure and portal pressure in stenotic (n = 7) or control rats (n = 13). In addition, a significant correlation was obtained for intrasplenic pressure and portal pressure in both stenotic and control rats (Fig. 1) .
Portal-Systemic Shunting
High-grade PSS was found in stenotic rats (96.2 t 0.7%), ranging from 91 to 99%. In control rats PSS was minimal, ranging from 0.1 to 1.7% (0.6 t 0.2% P < 0.001). Portal Venous Inflow
The portal venous inflow, which represented the total blood flow entering into the portal venous system, was increased by over 50% in stenotic rats (23.46 t 2.54 ml/ min) compared with control rats (14.97 t 1.61 ml/min P < 0.01). The elevated PVI in stenosis rats was due to similar blood flow increases in its respective components, the stomach, intestines, and spleen (Table 1) . Stenotic rats had an increase of 87% in gastric blood flow, 56% in intestinal blood flow, and 56% in splenic blood flow.
Splanchnic Resistance
Accompanying the increased blood flow to the splanchnit organs in stenotic rats, the arteriolar resistance in these organs was reduced ( Table 1 ). The splanchnic arteriolar resistance likewise was reduced in stenotic rats (3.86 + 0.43 vs. 7.60 t 0.80 dyn+cmW5 x 105; P < 0.001).
Portal Venous Resistance
Portal venous resistance was no different in stenotic rats (4.77 t 0.57 dyn s. crne5 X 104) and control rats (4.82 t 0.43 dyn~*crn-~ x 104; P = NS). Portal venous resistance in control rats is primarily a calculation of intrahepatic resistance to portal venous blood flow. In stenotic rats, portal venous resistance would estimate the total resistance of the collateral vessels plus the portal vein stenosis and would be nearly equivalent to the portalcollateral resistance.
Hepatic Blood Flow
In stenotic rats hepatic arterial flow was doubled with a tenfold reduction in portal venous blood flow; however, total hepatic blood flow was only decreased by one-half (Table 2 ).
Systemic Hemodynamics in
Both cardiac output and cardiac index were elevated stenosis rats (Table 3 ). The mean arterial pressure was Values are means -+ SE.
lower in stenotic rats, reflecting the reduced total peripheral resistance. A correlation between total peripheral resistance and splanchnic arteriolar resistance in both stenotic and control rats was obtained (r = 0.67; P < 0.01). The hepatic arterial flow percentage of cardiac output (3.6 t 0.4 vs. 4.1 t 0.4%; P = NS) and portal venous inflow percentage of cardiac output (16.6 t 1.77 vs. 14.9 t 1.5%; P = NS) were not significantly different in stenotic rats compared with control rats. Stenotic rats had an increased renal blood flow compared with control rats (4.08 t 0.28 vs. 2.92 t 0.29 ml. min-l . g-l; P < 0.01). No significant difference in blood flow to other organs, testes (0.26 t 0.02 vs. 0.27 t 0.02 ml. min-' l g-l), left br ain (2.71 t 0.38 vs. 2.70 t 0.34 ml* min. g-l), muscle (0.18 t 0.02 vs. 0.13 t 0.01 n&rnirP l g-l), skin (0.15 t 0.02 vs. 0.13 t 0.01 mlmin-' l g-l), and lung (3.69 t 0.73 vs. 3.61 t 0.90 mlmin-log-'), occurred in stenotic rats versus control rats, respectively.
DISCUSSION
The following conclusions can be drawn from this study performed in an animal model of prehepatic portal hypertension and portal-systemic shunting. First, the blood flow into the portal venous system was increased with a corresponding reduction in splanchnic arteriolar resistance, supporting the forward flow theory of portal hypertension. Second, although portal systemic shunting of nearly 100% reduced portal venous resistance to control values, the increased portal pressure was not similarly affected, indicating that the portal venous inflow rather than portal venous resistance was the primary reason for the chronic portal hypertension in this experimental model. Third, a systemic circulatory state characterized by an elevated cardiac index and reduced total peripheral resistance accompanied the increased portal venous inflow. Fourth, a compensatory elevation of hepatic arterial flow was maintained during the course of chronic diversion of portal venous flow away from the liver.
The hemodynamic finding of an elevated portal venous inflow in this model supports the forward flow theory of portal hypertension.
The converse of this observation would be a portal-hypertensive model with a high fixed resistance in the portal system and a secondary passive congestion of the portal venous system. Implicit with this latter model is a reduced portal venous inflow and an increased vascular resistance in the splanchnic organs. Moreno et al. (18) found that portal blood flow measured by electromagnetic flowmeters was decreased in cirrhotic patients with portal hypertension. Based on that finding, they calculated, using a Wheatstone bridge model (2) , that an increased resistance to splanchnic blood flow would be present (18). Their study provides the strongest support of the backward flow theory of portal hypertension. Their conclusions, however, are misleading due to the misconception that measurement of portal blood flow, or even total hepatic blood flow, in patients with portal hypertension provides sufficient data for predicting the changes that occur in the splanchnic circulation. Because the collateral circulation in most cirrhotic patients and animal models with portal hypertension carries a larger percentage of the total portal blood flow (4, 6), the hemodynamic conclusions one reaches can be erroneous unless the blood flow through the collarteral circulation is taken into account as in this present study.
This model of chronic portal hypertension unequivocally demonstrates that an elevated splanchnic blood flow and reduced splanchnic arteriolar resistance accompany chronic elevations in portal venous pressure. Other information has been accumulated that favors the forward flow theory of portal hypertension: a hyperdynamic systemic circulation (elevated cardiac index and reduced peripheral vascular resistance) in cirrhotic patients (20)) a shortened mean transit time of labeled albumin injected into the splanchnic circulation of cirrhotic patients (15), and an increased splenic blood flow with a concomitantly reduced splenic vascular resistance in portal-hypertensive patients (5,29). The experiments of Moritz et al. (19) and Levy (17) give partial support to our observations. They noted an increased splanchnic blood flow in dogs with intrahepatic portal hypertension induced by dimethylnitrosamine (17, 19). In neither of these studies, however, was the role of the increased splanchnic blood flow in maintaining the portal hypertension determined.
In the portal vein-stenotic rat model, the collateral vessels are created from the passive dilatation of preexisting venous channels in an attempt to decompress the hypertensive portal venous system (10). Once the collateral vessels have formed, the portal-collateral resistance in stenotic rats is not different from the intrahepatic resistance to portal venous blood flow in control rats. Collateral vessel formation produces a progressive reduction in portal venous resistance that abolishes resistance as the primary factor for the increased portal pressure. Of particular interest is that the portal pressure remained ele vated, despite the presence of high-grade portal-systemic shunting. By pressure criteria alone, portal-systemic shuntinghas inadeq uately decompressed the portal system. More important, this finding indicates that the primary reason for the chronically elevated portal pressure in this model is not an abnormally high resistance to portal venous blood flow but rather a direct function of the increased portal venous inflow. Thus, the ability of naturally occurring portal-systemic shunting to decompress a hypertensive portal venous system may be limited principally by the portal venous inflow.
Perhaps the most intriguing and elusive phenomenon is to explain why the portal venous inflow increases to such a disproportionate degree and perpetuates the portal hypertension. The results suggest that the increased portal venous inflow is not the result of the elevated cardiac index but instead is part of a generalized vasodilation within the splanchnic vascular bed. If the increased cardiac index is the primary factor for the hyperdynamic portal venous inflow, blood flow to other organs, such as testes, brain, skin, muscle, would also be increased. Because blood flow is increased only in the splanchnic organs, one might assume that the elevated cardiac index is the response and therefore the consequence of an increased blood flow demand within the splanchnic organs. The elevated renal blood flow, being the only exception, perhaps is mediated through the same humoral or neurogenic factors that produce the active vasodilation of the splanchnic organs. One such humoral factor might be prostacyclin (PGIZ), a potent vasodilator of the renal and splanchnic beds. A recent study has shown an increased release of PGIZ-like activity from the portal vein in this animal model (12). This PGIZ activity could be one of the mediators responsible for the hemodynamic changes found in this study.
* The potential role of portal-systemic shunting to induce changes in the portal venous inflow also cannot be ignored. Because portal-systemic shunting diverts a large quantity of portal blood flow away from the liver, portal blood flow perfusing the hepatic sinusoids is greatly reduced. A feedback mechanism from the liver to the splanchnic bed may be postulated that acts to increase the portal venous inflow as a compensatory measure from the loss of portal blood flow. Potential signals for this feedback might result from 1) reduced oxygen delivery to the liver from portal venous blood (16), 2) reduced delivery of metabolic substrates or hepatotrophic factors such as glucagon (25), or 3) a neurogenic response mediated by the sympathetic nervous system or related to proposed portal venous baroreceptors (22). An increased splanchnic blood flow has also been observed in cirrhotic dog models of portal hypertension (17, 19). Therefore, the mechanism that modulates the hyperdynamic splanchnic circulation should be common to both models, the cirrhotic dog and the prehepatic portal-hypertensive model described here. Athough this conclusion is not helpful in determining the cause of the hyperdynamic circulation, it could be useful in excluding causes that are not common to both models, i.e., sinusoidal pressure. Hepatic sinusoidal pressure is increased in cirrhotic models but normal or low in the prehepatic model. The cardiac output and index are also markedly elevated with reductions in the total peripheral resistance and mean arterial pressure. The correlation between total peripheral resistance and total splanchnic resistance suggests that the changes in total peripheral resistance are secondary to the reduced splanchnic resistance. Portal-systemic shunting by decreasing splanchnic arteriolar resistance and increasing splanchnic blood flow appears to act in an analogous hemodynamic manner to an arteriovenous fistula (3 1).
The doubling of hepatic arterial flow in stenotic rats demonstrates the reciprocal nature of the hepatic artery to chronic reductions in portal venous blood flow. The reciprocity of hepatic arterial flow has been shown to occur during acute reductions in portal blood flow (13, 26); however, it has not been clearly demonstrated after a long-term reduction in portal blood flow (3, 23). The increased hepatic arterial flow observed in this study also appears to be part of the vasodilation in the splanchnic vascular bed.
This model of portal hypertension provides a conceptual framework for understanding the hemodynamic alterations observed in portal hypertension. One association emerging from this study is the presence of highgrade portal-systemic shunting with these hemodynamic ch .anges. Portal-systemic shunting is shown by this model to reduce portal-collateral resistance with the net effect of partially dedompressing a hypertensive portal system. Portal-systemic shunting relegates the initial fixed extrahepatic site of portal venous resistance to a position of lesser, if not minor, importance in the total hemodynamic structure of the portal system. The portal venous inflow in this scheme now becomes the major determinant of portal venous pressure. More important, the elevated portal venous inflow has modified the portal venous hemodynamic state into a highly dynamic system with increased blood flows, particularly within the collateral vasculature (8). This model provides credence to the forward flow theory of portal hypertension and suggests that the increased blood flow into the portal system may be a major mechanism for the maintenance of chronic portal hypertension in the presence of high-grade portalsystemic shunting.
